Marcus evans to Host the Strategies in Patient Centered Clinical Research Conference

This marcus evans meeting will take a look at all aspects of patient centered clinical trials from trial design, operations, the role of the digital age, and patient advocacy groups. In addition, the event will address the challenges and misconceptions of the regulatory environment and explore the economic value of incorporating the patient voice.

News provided by

marcus evans

Jun 06, 2016, 10:39 ET

BOSTON, June 6, 2016 /PRNewswire/ -- The Strategies in Patient Centered Clinical Research Conference on July 20-21, 2016, will bring the patient voice to focus. Clinical research is gearing towards greater patient engagement. Drug companies are incorporating trends and technologies that allow patients to become more actively involved in clinical trials. In order to ensure a high level of patient participation, companies must bring the patient voice to the forefront of the trial.

Attending this advanced conference will enable you to:

Incorporate the patient voice in all stages of clinical research for heightened patient participation
Establish metrics to evaluate the ROI on patient centric programs
Overcome internal resistance to becoming a patient centric organization
Collaborate with key stakeholders to encourage patient driven healthcare
Manage unique challenges of the digital age as patients are becoming more empowered with their health

Featuring Case Studies from Leading Life Science Experts, including:

Jeremy D. Jokinen, Ph.D., MS, PSTAT, Senior Director, Patient-Centered Safety Outcomes, AbbVie
Michael Greenberg, MD, MPH, Associate Vice President, Innovation & Patient Centricity, Sanofi Pasteur
Helena Chung, Director, Patient Centricity Excellence, AstraZeneca
Stella Stergiopoulos, Senior Project Manager, Tufts Center for the Study of Drug Development
Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly and Company
John J. Whyte, M.D., M.P.H., Director of Professional Affairs and Stakeholder Engagement Center For Drug Evaluation and Research (CDER), U.S. Food and Drug Administration
Andrew Schorr, Founder & President, Patient Power, LLC

Testimonials:

"I continue to be impressed by the quality of speakers and depth of content at each marcus evans event." AstraZeneca

"Up to date, stimulating and interactive meeting. Enthusiastic audience and high quality speakers." Shire Pharmaceuticals

Check out the conference brochure or email Tyler Kelch, Digital Marketing Manager at [email protected]

marcus evans annually produces 2,000 high quality conferences designed to provide strategic business information and networking opportunities for industry leaders.

Logo - http://photos.prnewswire.com/prnh/20160517/368864LOGO

SOURCE marcus evans